BioPharma Credit (BPCR)

Index:

FTSE 250

$ 0.89
   
  • Change Today:
    $0.00
  • 52 Week High: $0.9
  • 52 Week Low: $0.8
  • Currency: US Dollars
  • Shares Issued: 1,129.13m
  • Volume: 20,614
  • Market Cap: $1,009.44m
  • RiskGrade: 32

BPCR Overview

BioPharma Credit plc provides investors with an opportunity to gain exposure to the fast growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. BioPharma Credit’s primary objective is to generate predictable income for shareholders over the long term.

Key Personnel

Chairman: Harry Abraham Hyman
Independent Non-Executive Director: Colin Bond
Independent Non-Executive Director: Rolf Soderstrom
Independent Non-Executive Director: Stephanie Léouzon
Senior Independent Director: Duncan W A Budge
Non-Executive Dir: Sapna Shah

Contact Details

Address: 51 New North Road, Exeter, United Kingdom, EX4 4EP
Phone: +44 (0)1392 477500
Website: http://www.bpcruk.com

Listings

Index: FTSE 250, FTSE 350, FTSE All-Share
Domestic Listings: LSE:BPCP
ISIN: GB00BDGKMY29

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BPCR Market Data

Currency US Dollars
Share Price $ 0.89
Change Today $ 0.00
% Change -0.22 %
52 Week High $0.9
52 Week Low $0.8
Volume 20,614
Shares Issued 1,129.13m
Market Cap $1,009.44m
RiskGrade 32

BPCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

BPCR Dividends

  Latest Previous
  Special 3rd Interim
Ex-Div 25-Sep-25 25-Sep-25
Paid 31-Oct-25 31-Oct-25
Amount 1.50¢ 1.75¢

Trades for 05-Nov-2025

Time Volume / Share Price
09:31 10,000 @ $0.90
09:10 3,000 @ $0.91
09:09 1,410 @ $0.90
08:57 1 @ $0.91
08:35 4,250 @ $0.90

BPCR Key Personnel

Chair Harry Abraham Hyman

Top of Page